MIM
TTPH

Monashee Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Monashee Investment Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,000
Closed -$733K – 109
2015
Q1 		$733K Buy
+1,000
New +$751K 0.46% 53

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Monashee Investment Management's TTPH Position: Q2 2015 in Review

Monashee Investment Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2015, closing a stake of 1,000 shares — an estimated $733K sold.

Monashee Investment Management first reported a position in TTPH in Q1 2015 and held it in 1 quarter. The position peaked at $733K in Q1 2015. 139 funds tracked by Wall St. Rank hold TTPH as of Q2 2015.

  • Monashee Investment Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Monashee Investment Management sold 1,000 Tetraphase Pharmaceuticals, Inc. shares in Q2 2015, an estimated $733K.
  • Monashee Investment Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Monashee Investment Management's Tetraphase Pharmaceuticals, Inc. position peaked at $733K in Q1 2015.
  • 139 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2015.

Based on Monashee Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.